Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vestas - Interim financial report, second quarter 2017

In the second quarter of 2017, Vestas generated revenue of EUR 2,206m – a decrease of 14 percent compared to the year-earlier period. EBIT decreased by EUR 120m to EUR 279m. The EBIT margin was 12.6 percent compared to 15.6 percent in the second quarter of 2016 and free cash flow* amounted to EUR (158)m compared to EUR 330m in the second quarter of 2016.  The intake of firm and unconditional wind turbine orders amounted to 2,667 MW in the second quarter of 2017. The value of the wind turbine order backlog amounted to EUR 9.1bn at 30 June 2017. In addition to the wind turbine order

Autoliv starts collaboration with Seeing Machines to develop Driver Monitoring Systems

(Stockholm, Sweden, August 17, 2017) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, will collaborate with Seeing Machines (AIM:SEE), a leader in computer vision based human sensing technologies, to develop next generation driver monitoring systems (DMS) for autonomous vehicles.According to the National Highway Traffic Safety Administration, in the United States 3,477 people were killed, and 391,000 were injured, in motor vehicle crashes involving distracted drivers in 2015 alone. The American Automobile Association also states that 21% of

Bambuser signs contract with Double Dutch

Bambuser AB (publ) ("Bambuser" or "The Company") has signed a one-year contract with Double Dutch, Inc, an event engagement company.Bambuser has signed a one-year agreement with Double Dutch for their event platform, concerning the Company's product Iris Dev. The contract, which will run over a minimum of one year, has a total license value of 235,000 SEK and additional variable revenue might occur based on usage. The agreement will be made effective from August 2017. Double Dutch is a leader in the live engagement space which powers events, conferences and trade shows and adding mobile

Interim Report period from January 2017 to June 2017

Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED) 2017 SECOND QUARTER (Apr-Jun) · Operating loss KSEK -2,559 (-2,770)  · Loss per share SEK -0.12 (-0.14) 2017 FIRST HALF YEAR (Jan-Jun) · Operating loss KSEK -5,240 (-6,321) · Loss per share SEK -0.25 (-0.33)IMPORTANT EVENTS DURING THE PERIOD · On March 10th, the Company announced that the primary efficacy endpoints of the first part of its phase 2b study, in which the Vagitocin® gel was investigated for the treatment of vaginal atrophy, were not met. However, further analyses of

Interim report January – June 2017

Interim report January-June 2017 · Net asset value per share at 30 June 2017 was SEK 104.09, compared to SEK 101.74 at the end of the previous year, which represents an increase of 2.3 per cent. · Bure’s net asset value was SEK 7,217M, compared to SEK 7,054M at year-end 2016. · Total return on the Bure share was -3.6 per cent, compared to the SIX Return Index which rose by 10.8 per cent. · Consolidated profit after tax was SEK 312M (364). Earnings per share amounted to SEK 4.49 (5.25). Second quarter 2017 · Net asset value per share was SEK 104.09, compared to SEK 101.

Cherry adjusts full-year forecast

All of the Cherry Group business areas are performing well but the ComeOn! integration has not yet reached a full positive impact. Thus, the Company adjusts its full-year forecast for 2017.Cherry AB (publ) shows continued strong development in all business areas with profitable growth. In December 2016, in connection with Cherry calling the option to acquire the remaining 51% of the shares in ComeOn Malta Ltd, the Group provided a forecast. The Cherry Group, together with acquired ComeOn, was estimated to generate total revenue for the full year 2017 of between SEK 2,600 and SEK 2,700

YIT brings openness to the housing markets in Prague and Bratislava

YIT CORPORATION News, August 17, 2017 at 09:30 a.m.YIT is better known in the Czech Republic and Slovakia than ever before. The company has several major projects underway in both countries. YIT has also brought Nordic openness to housing project planning. Over the past ten years, YIT has reached a solid position in the Czech and Slovak housing markets. The company’s subsidiaries in the countries are YIT Slovakia in Bratislava and YIT Stavo in Prague. “We are among the top three housing developers in the area. Our company is known for its high quality and reliability,” says Milan

Interim report, January-June 2017 Rabbalshede Kraft AB (publ)

Production for the second quarter totaled 108,381 MWh (87,664) · Net sales amounted to KSEK 49,135 (39,643) · EBITDA totaled KSEK 23,505 (9,194) · EBIT amounted to KSEK 981 (loss: 13,221) · Average income for wind-power production was SEK 453/MWh (452), of which electricity accounted for SEK 311/MWh (301) and electricity certificates and guarantees of origin for SEK 142/MWh (151)First six months, January-June 2017 · Production from the Group’s wind farms during January-June amounted to 246,440 MWh (212,050).· Net sales totaled KSEK 109,807 (94,445).· EBITDA amounted to KSEK 48,885 (

NeuroVive Pharmaceutical AB Interim report January - June 2017

Strategic in-licensing broadens the project portfolioBusiness operations Significant events April-June 2017 · The anti-fibrotic effects of NV556 in non-alcoholic steatohepatitis (NASH) was confirmed in an additional experimental model. The preclinical data was presented at The International Liver Congress™ in Amsterdam.  · At the Annual General Meeting on 27 April, two new board members were elected: Jan Törnell, adjunct Professor at the Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, and David Bejker, CEO of Affibody Medical AB  ·

BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2017

Biohit Oyj Half Year Financial Report 17 August 2017 at 9:30 am local time (EEST) SUMMARY January-June 2017 · Net sales grew by 6.7 % compared to H1/2016 · Net sales EUR 4.1 million (EUR 3.8 million) · Operating profit EUR 7.4 million including the profit of EUR 8.4 million booked from the joint venture exit (EUR -2.1 million) · The profit for the reporting period was EUR 7.2 million (EUR -2.1 million) · Net sales from international operations 95.0 % (90.5 %) of total net sales · Equity ratio 89.6 % (85.4 %)   PRESIDENT AND CEO SEMI KORPELA: ”During the

Powerbox releases full range of high input voltage DC/DC converters for microgrids and datacenters

Powerbox , one of Europe’s largest power supply companies and a leading force for four decades in optimizing power solutions for demanding applications, has announced a new range of high-voltage input DC/DC converters for microgrid, datacenters and industrial applications. Part of its industrial line, the new series of HVDC/DC converters operate with an input voltage range of 180VDC to 425VDC, and deliver output power levels from 150W to 750W. The range of applications powered by high-voltage DC supplies is rapidly expending, and from the latest microgrids and

Interim report – Second quarter and first half-year of 2017

Attached please find the full report as PDF file. ________________________________________________________________________________ Announcement no. 7 17 August 2017 Interim report – Second quarter and first half-year of 2017 Today, the Board of Directors approved the interim report for the second quarter and first half-year of 2017. The full report in English is attached as PDF file and contains the following highlights: · Results             Adjusted result for Q2 2017: USD -3 million (Q2 2016: USD -4 million)             - Dry Cargo: USD -7 million (USD -11

Kamux Oyj: Kamux's 40th car showroom in Finland has opened in Espoo

Kamux's 40th car showroom in Finland has opened in Espoo Kamux, a company specializing in used car sales, has opened its 40[th] car showroom in Finland. The showroom is located in Olarinluoma, Espoo. With a new showroom Kamux gains a firmer foothold on the used cars market in the metropolitan area. "With our new showroom, we are gaining an even firmer foothold on the used cars market in Finland. We already have one showroom in Espoo and a total of seven showrooms in the metropolitan area", says Jussi Mäkinen, Finnish Country Director. The location of the new showroom was chosen

Acando Interim report January 1-June 30, 2017

Second quarter April 1 – June 30, 2017 · Net sales totaled SEK 613 m (578) · Operating profit amounted to SEK 55 m (62) · The operating margin was 9.0% (10.7) · Profit after tax was SEK 41 m (62) · Earnings per share were SEK 0.40 (0.60) Accumulated January 1 – June 30, 2017 · Net sales totaled SEK 1,234 m (1,104) · Operating profit amounted to SEK 130 m (96) · The operating margin was 10.5% (8.7) · Profit after tax was SEK 95 m (86) · Earnings per share were SEK 0.93 (0.83) · Cash and cash equivalents totaled SEK 56 m (64)Statement by Carl-Magnus

Invitation to AddLife’s Capital Markets Day 6 September 2017

Hereby analysts, investors and media are welcomed to Capital Markets Day Wednesday on 6 September 2017 9:00am at Scandic Anglais, Humlegårdsgatan 23, Stockholm. Registration from 8:30am whilst coffee and sandwich will also be offered. AddLife’s CEO Kristina Willgård will speak, together with the management. The purpose of the Capital Markets Day is uppermost to portray the company’s development and further strategy as well as to present the acquisitions of the previous year. Registration is made to martin.almgren@add.life on 4 September at the latest. Should there be any questions,

Wilson Therapeutics to host conference call to provide second quarter 2017 business update

On August 24 17, 2017, at 08:00 CET, Wilson Therapeutics will publish its interim report for the second quarter 2017. All interested parties are invited to participate in a web-cast telephone conference, which will include a presentation, on the same day at 10:00 CET. The event will be hosted by Wilson Therapeutics’ CEO Jonas Hansson and CFO Anders Martin-Löf, and the presentation will be held in English.How to participateThe live webcast and a recorded on-demand version including the presentation material will be accessible at: https://tv.streamfabriken.com/wilson-therapeutics-q2-2017.

AQ Group AB (publ), interim report January - June, 2017

Second quarter, April- June 2017in brief · Net sales increased by 25% to SEK 1 077 million (860) · Operating profit (EBIT) decreased by 19 % to SEK 74 million (92) · Profit after financial items (EBT) decreased by 22 % to SEK 70 million (91) · Profit margin before tax (EBT %) 6.5% (10.6) · Cash flow from operating activities increased by 3 % to SEK 79 million (76) · Equity ratio 60 % (60) · Earnings per share after tax decreased by 23 % to SEK 3.20 (4.18) Six months, January - June 2017in brief · Net sales increased by 25% to SEK 2 079 million (1 661) ·

Catella launches “Catella Modernes Wohnen” open-ended mutual real estate fund for small-scale, affordable living

The team of Catella Real Estate AG has launched “Catella Modernes Wohnen” - an open-ended mutual real estate fund. The fund invests in small-scale, and thus affordable, accommodation with a focus on one and two person households in German conurbations.Over 75% of households in Germany are one and two person households, but one room apartments account for only 3% of Germany’s housing stock; if 2-3-room apartments are included, the share is 30%. The average residential unit size of 95 m² realised in new construction is not in line with demand. The new fund will invest in small-scale and

Eltel Group: Interim Report January–June 2017

January–June 2017 · Group net sales amounted to EUR 627.6 million (656.6), down 3.8% in local currencies · Group operative EBITA amounted to EUR -30.7 million (8.9)* · EBIT amounted to EUR -183.0 million (1.7) including a goodwill impairment of EUR 145.6 million · The net result amounted to EUR -185.9 million (-3.7) · Earnings per share were EUR -1.76 (-0.04) · Operative cash flow was EUR -77.1 million (-53.1) April–June 2017 · Group net sales amounted to EUR 329.8 million (369.0), down 9.5% in local currencies · Group operative EBITA amounted to EUR -21.0

Change in Eltel’s Group Management Team

Thomas Rebermark has been appointed head of Marketing and Communications and member of the Group Management Team as of 1 November 2017. He is joining from Rejlers AB where he has the position as Group Marketing and Communications Director. Ingela Ulfves, VP – IR and Group Communications and member of the Group Management Team will leave Eltel to take up a new position at Fortum Oyj. She continues in her position at Eltel until the end of October 2017. For further information:Ingela Ulfves VP – IR and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com

Alimak Group: Interim report January – June 2017

Strong growth in the quarter·  Solid order intake, revenue and result ·  Continued strong performance in Construction Equipment and After Sales   ·  Integration according to plan and significant contribution on order intake and revenues from acquired businesses Second quarter ·  Order intake increased by 120% to MSEK 1,193 (543) with organic growth of 14% ·  Revenue increased by 128% to MSEK 1,194 (524) with organic growth of 20% ·  EBITA adj. increased to MSEK 173 (92), margin 14.5% (17,6) ·  EBITA increased to MSEK 171 (92), margin 14.3% (17,6) ·  EBIT increased

BONESUPPORT HOLDING AB (publ) - Interim Report January - June 2017

Lund, Sweden, 08.00 CEST, 17 August 2017 – BONESUPPORTTM, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT™ platform today publishes its Interim Report, January-June 2017. FINANCIAL HIGHLIGHTS Q2 Net sales increased by 48%  APRIL – JUNE 2017 ·  Net Sales amounted to SEK 37.1 million (25.2), an increase of 48% ·  Gross margin of 87.2% (86.1) ·  Operating loss of SEK -18.4 million (-20.8) ·  Earnings per share, before and after

Ingela Ulfves appointed as Vice President, Investor Relations and Financial Communications at Fortum

FORTUM CORPORATION PRESS RELEASE 17 August 2017Ingela Ulfves, M.Sc. (Econ.), has been appointed Vice President, Investor Relations and Financial Communications at Fortum starting in December 2017 at the latest. She will report to Fortum’s CFO Markus Rauramo.Ingela Ulfves joins Fortum from Eltel, an infrastructure service company listed in Sweden, where she has been responsible for the areas of investor relations, external and internal communications, marketing and brand. Prior to Eltel, she was heading investor relations and group communications at Tokmanni Group, the largest discount

Ratos: Interim report January-June 2017

P R E S S   R E L E A S E  17 August 2017  This information is information that Ratos AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on 17 August 2017. Development in company portfolio · Sales growth +2% · EBITA amounted to SEK 757m (625), +21% · Adjusted EBITA totalled SEK 777m (806), -4% Acquisitions and divestments · Agreement signed for the divestment of Nebula, exit gain SEK 515m.

There are no items matching the current filter
There are no more items matching the current filter
Back to top